Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study.

导出 OA

翻译打印收藏纠错

作者： Raffaele,Parrozzani ^[1] ; Giuseppe,Lombardi ^[2] ; Edoardo,Midena ^[3] ; Francesca,Leonardi ^[1] ; Davide,Londei ^[1] ; Marta,Padovan ^[2] ; Mario,Caccese ^[2] ; Giulia,Marchione ^[1] ; Silvia,Bini ^[1] ; Vittorina,Zagonel ^[2] ; Luisa,Frizziero ^[4]

作者单位： Department of Ophthalmology, University of Padova, Padova, Italy. ^[1] Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy. ^[2] Department of Ophthalmology, University of Padova, Via Giustiniani 2, Padova, 35128, Italy IRCCS - Fondazione Bietti, Rome, Italy. ^[3] IRCCS - Fondazione Bietti, Rome, Italy. ^[4]

关键词 ABT-414 EGFR-inhibitor confocal microscopy cornea depatuxizumab mafodotin epithelium glioblastoma head and neck cancer side effects subbasal nerve plexus

DOI 10.1177/1758835920907543

PMID 32550861

发布时间 2022-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in medical oncology

2020年12卷

1758835920907543页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Corneal side effects induced by EGFR-inhibitor antibody-drug conjugate ABT-414 in patients with recurrent glioblastoma: a prospective clinical and confocal microscopy study.

Therapeutic advances in medical oncology

相似文献

Therapeutic advances in medical oncology

相关期刊

检索历史清除